Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis
Open Randomised Prospective Comparative Multi-centre Intervention Study of Patients With Cystic Fibrosis and Early Diagnosed Diabetes Mellitus
Sponsor: Assistance Publique - Hôpitaux de Paris
Listed as NCT00662714, this PHASE3 trial focuses on Cystic Fibrosis and Diabetes Mellitus and remains completed. Sponsored by Assistance Publique - Hôpitaux de Paris, it has been updated 6 times since 2001, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Sep 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
- Mucoviscidose-ABCF2
- Mukoviszidose Institut gGmbH
- Novo Nordisk A/S
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Berlin, Germany , Bremen, Germany , Cologne, Germany , Düsseldorf, Germany , Erlangen, Germany , Essen, Germany , Frankfurt, Germany , Gerlingen, Germany , Graz, Austria , Greifswald, Germany and 19 more locations